Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro

Bone

Volumn 45, Issue 2, 2009, Pages 309-320

  Wang, Liping ^a,b   Zhao, Rong ^a,b   Shi, Xiaoyou ^a,b   Wei, Tzuping ^a,b   Halloran, Bernard P ^c,d   Clark, David J ^a,b   Jacobs, Christopher R ^a,e   Kingery, Wade S ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Stanford University   (United States)

Author keywords

Bone marrow stromal cell; Mouse; Neuropeptide; Osteoblast; Osteoclasts; Osteogenesis; Substance P

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BROXURIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROKININ 1 RECEPTOR; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; SUBSTANCE P; SUBSTANCE P RECEPTOR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE TURNOVER; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; MULTINUCLEAR CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SENSORY NERVE CELL; STROMA CELL; WESTERN BLOTTING;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICROSCOPY, CONFOCAL; NF-KAPPA B; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PROTEIN TRANSPORT; RANK LIGAND; RECEPTORS, IMMUNOLOGIC; STEM CELLS; STROMAL CELLS; SUBSTANCE P;

EID: 67649452522     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.04.203     Document Type: Article

References (49)

1. Imai S., and Matsusue Y. Neuronal regulation of bone metabolism and anabolism: calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc. Res. Tech. 58 (2002) 61-69
2. Hill E.L., and Elde R. Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell. Tissue Res. 264 (1991) 469-480
3. Mach D.B., Rogers S.D., Sabino M.C., Luger N.M., Schwei M.J., Pomonis J.D., et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113 (2002) 155-166
4. Offley S.C., Guo T.Z., Wei T., Clark J.D., Vogel H., Lindsey D.P., et al. Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J. Bone Miner. Res. 20 (2005) 257-267
5. Pearson J., Dancis J., Axelrod F., and Grover N. The sural nerve in familial dysautonomia. J. Neuropathol. Exp. Neurol. 34 (1975) 413-424
6. Maayan C., Bar-On E., Foldes A.J., Gesundheit B., and Pollak R.D. Bone mineral density and metabolism in familial dysautonomia. Osteoporos. Int. 13 (2002) 429-433
7. Maayan C., Becker Y., Gesundheit B., and Girgis S.I. Calcitonin gene related peptide in familial dysautonomia. Neuropeptides 35 (2001) 189-195
8. Gamse R., Leeman S.E., Holzer P., and Lembeck F. Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn. Schmiedebergs Arch. Pharmacol. 317 (1981) 140-148
9. Kashiba H., Ueda Y., and Senba E. Systemic capsaicin in the adult rat differentially affects gene expression for neuropeptides and neurotrophin receptors in primary sensory neurons. Neuroscience 76 (1997) 299-312
10. Goto T., Yamaza T., Kido M.A., and Tanaka T. Light- and electron-microscopic study of the distribution of axons containing substance P and the localization of neurokinin-1 receptor in bone. Cell. Tissue Res. 293 (1998) 87-93
11. Goto T., Kido M.A., Yamaza T., and Tanaka T. Substance P and substance P receptors in bone and gingival tissues. Med. Electron. Microsc. 34 (2001) 77-85
12. Goto T., Nakao K., Gunjigake K.K., Kido M.A., Kobayashi S., Tanaka T., et al. stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 41 (2007) 25-31
13. Togari A., Arai M., Mizutani S., Mizutani S., Koshihara Y., and Nagatsu T. Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells. Neurosci. Lett. 233 (1997) 125-128
14. Shih C., and Bernard G.W. Neurogenic substance P stimulates osteogenesis in vitro. Peptides 18 (1997) 323-326
15. Adamus M.A., and Dabrowski Z.J. Effect of the neuropeptide substance P on the rat bone marrow-derived osteogenic cells in vitro. J. Cell. Biochem. 81 (2001) 499-506
16. Azuma H., Kido J., Ikedo D., Kataoka M., and Nagata T. Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis. J. Periodontol. 75 (2004) 974-981
17. Bjurholm A., Kreicbergs A., Schultzberg M., and Lerner U.H. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells. J. Bone Miner. Res. 7 (1992) 1011-1019
18. Liu F., Malaval L., and Aubin J.E. Global amplification polymerase chain reaction reveals novel transitional stages during osteoprogenitor differentiation. J. Cell. Sci. 116 (2003) 1787-1796
19. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
20. Shui C., Spelsberg T.C., Riggs B.L., and Khosla S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J. Bone Miner. Res. 18 (2003) 213-221
21. Mori T., Ogata T., Okumura H., Shibata T., Nakamura Y., Kataoka K., et al. regulates the function of rabbit cultured osteoclast; increase of intracellular free calcium concentration and enhancement of bone resorption. Biochem. Biophys. Res. Commun. 262 (1999) 418-422
22. Sohn S.J. Substance P upregulates osteoclastogenesis by activating nuclear factor kappa B in osteoclast precursors. Acta Otolaryngol. 125 (2005) 130-133
23. Cao J.J., Singleton P.A., Majumdar S., Boudignon B., Burghardt A., Kurimoto P., et al. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J. Bone Miner. Res. 20 (2005) 30-40
24. Nauman E.A., Sakata T., Keaveny T.M., Halloran B.P., and Bikle D.D. bFGF administration lowers the phosphate threshold for mineralization in bone marrow stromal cells. Calcif. Tissue Int. 73 (2003) 147-152
25. Wang M.W., Wei S., Faccio R., Takeshita S., Tebas P., Powderly W.G., et al. The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. J. Clin. Invest. 114 (2004) 206-213
26. Rameshwar P., and Gascon P. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86 (1995) 482-490
27. Rameshwar P., Ganea D., and Gascon P. In vitro stimulatory effect of substance P on hematopoiesis. Blood 81 (1993) 391-398
28. Rameshwar P., Poddar A., Zhu G., and Gascon P. Receptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibroblasts. J. Immunol. 158 (1997) 3417-3424
29. Keselowsky B.G., Collard D.M., and Garcia A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5953-5957
30. Huhtakangas J.A., Olivera C.J., Bishop J.E., Zanello L.P., and Norman A.W. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol. Endocrinol. 18 (2004) 2660-2671
31. Li X., Shi X., Liang D.Y., and Clark J.D. Spinal CK2 regulates nociceptive signaling in models of inflammatory pain. Pain 115 (2005) 182-190
32. Yamashita T., Yao Z., Li F., Zhang Q., Badell I.R., Schwarz E.M., et al. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 282 (2007) 18245-18253
33. Goto T., and Tanaka T. Tachykinins and tachykinin receptors in bone. Microsc. Res. Tech. 58 (2002) 91-97
34. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143 (1990) 420-430
35. Matayoshi T., Goto T., Fukuhara E., Takano H., Kobayashi S., Takahashi T., et al. stimulates the formation of osteoclasts via synovial fibroblastic cells. Biochem. Biophys. Res. Commun. 327 (2005) 756-764
36. Kojima T., Yamaguchi M., and Kasai K. Substance P stimulates release of RANKL via COX-2 expression in human dental pulp cells. Inflamm. Res. 55 (2006) 78-84
37. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1566-1571
38. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
39. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., and Teitelbaum S.L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106 (2000) 1481-1488
40. Komarova S.V., Pereverzev A., Shum J.W., Sims S.M., and Dixon S.J. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2643-2648
41. Komarova S.V., Pilkington M.F., Weidema A.F., Dixon S.J., and Sims S.M. RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. J. Biol. Chem. 278 (2003) 8286-8293
42. Lieb K., Fiebich B.L., Berger M., Bauer J., and Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J. Immunol. 159 (1997) 4952-4958
43. Quinlan K.L., Naik S.M., Cannon G., Armstrong C.A., Bunnett N.W., Ansel J.C., et al. Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. J. Immunol. 163 (1999) 5656-5665
44. Marriott I., Mason M.J., Elhofy A., and Bost K.L. Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J. Neuroimmunol. 102 (2000) 163-171
45. Arai T., Yoshimi N., Fujiwara H., and Sekizawa K. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology 61 (2003) 1625-1626
46. Matucci-Cerinic M., Lombardi A., Leoncini G., Pignone A., Sacerdoti L., Spillantini M.G., et al. Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation. Rheumatol. Int. 13 (1993) 1-4
47. Grimsholm O., Rantapaa-Dahlqvist S., and Forsgren S. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Arthritis Res. Ther. 7 (2005) R416-R426
48. Pritchett J.W. Substance P level in synovial fluid may predict pain relief after knee replacement. J. Bone. Joint. Surg. Br. 79 (1997) 114-116
49. Sun J., Ramnath R.D., Zhi L., Tamizhselvi R., and Bhatia M. Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am. J. Physiol. Cell. Physiol. 294 (2008) C1586-C1596